Refine Results
- Products
- Content Type
- Analysis Platform
- Language
- Publication Date
1 - 4 of 4 results
Applied Filters
Using the Agilent LC/MSD XT in open access mode provides tremendous user flexibility to automate compound confirmation and purity/impurity analysis
The method shown provides an end-to-end solution for low detection limits of quantitation for ASOs in human plasma by combing sample preparation via SPE on an Agilent Bravo liquid handler combined with a standard flow liquid chromatogram coupled...
Enhance your targeted omics with a standardized LC/TQ platform.Our advanced LC/TQ technologies allow for the creation of large, multiplexed target lists for primary metabolites, lipids, and peptides.
| Chinese (Simplified) (China) | Complete (PDF) |
|---|---|
| Japanese (Japan) | Complete (PDF) |
| Korean (Korea) | Complete (PDF) |
本文詳細的介紹了蛋白（肽段）定量的意義及出現(xiàn) MRM 質(zhì)譜技術(shù)平臺的緣由、MRM 肽段定量的基本原理、安捷倫 MRM 肽段定量的完整定義以及安捷倫 LC/QQQ 肽段定量應(yīng)用實例等。